The immune system plays a crucial role in defending against infections and maintaining health. One critical component of the immune response is the production of antibodies, which specifically recognize and neutralize foreign invaders. For the first time, the researchers comprehensively analyzed the early antibody response during the first week of infection by a respiratory syncytial virus (RSV) in a non-human primate model.
The study revealed a striking difference between great apes, including humans, chimpanzees, and gorillas, and Old World monkeys, such as rhesus macaques. Contrary to expectations, apes exhibited rapid and strong antibody production within the first few days of infection, whereas the response in monkeys was significantly weaker and delayed.
"This result was truly surprising and prompted us to further investigate the underlying mechanisms," says Dr. Taisuke Fujii, a postdoctoral researcher at Kyoto University and first author of the study.
The researchers analyzed the gene activity in immune cells and found that genes associated with antibody production were more highly expressed in apes compared to monkeys, even before the infection. This suggests that apes may have an intrinsic advantage in quickly generating antibodies against viral infections.
"Our findings challenge the previously held notion that the immune responses of apes are slower than those of Old World monkeys," explains Professor Gen Sawa, the senior author of the study. "This discovery broadens our understanding of the evolution of immune systems and may provide clues to understanding the susceptibility and severity of viral infections in different primate species."
Understanding the diverse immune responses of primates offers valuable insights into human immunology and evolutionary biology. The researchers hope that their findings pave the way for further studies on the mechanisms driving these differences and contribute to the development of improved vaccines and treatments for infectious diseases.
